Streetbeat News

Stock Prices

ACN

Accenture (NYSE:ACN) reported Q3 2024 earnings per share of $3.13, missing the analyst estimate of $3.15. The company also reported sales of $16.467 billion, falling short of the $16.552 billion estimate. This represents a 0.59% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:39 am

NNVC

Nanoviricides announced that its Phase 2 drug candidate, NV-387, demonstrated effectiveness in protecting lungs from damage in a lethally infected influenza H3N2 mouse model.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:35 am

PTCT

PTC Therapeutics shared interim results from its Phase 2 PIVOT-HD study of PTC518 in Huntington's Disease, showing dose-dependent lowering of mutant huntingtin protein in blood/cerebrospinal fluid and favorable trends on several relevant clinical assessments. The FDA has lifted the partial clinical hold on PTC518 based on the PIVOT-HD data.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:34 am

NIO

NIO Inc. (NYSE:NIO) CEO William Li has expressed opposition to the European Union's newly imposed tariffs on Chinese electric vehicles (EVs). Despite the tariffs, NIO's upcoming Firefly models are expected to remain competitive in the European market. The EU plans to impose additional tariffs up to 38.1% on Chinese EVs, with an average of 21% for companies like NIO. A final decision on the tariffs is expected by October or November.

Portfolio Pulse from Nabaparna Bhattacharya

June 20, 2024 | 10:19 am

NVDA

QQQ

TSM

VOO

Nvidia Corp (NASDAQ:NVDA) has become the world's most valuable listed company due to surging demand for its AI chips, with its stock tripling in value over the past 12 months. Key supplier Taiwan Semiconductor Manufacturing Co (NYSE:TSM) is developing new chip packaging methods to meet AI-driven demand. Investors can gain exposure to Nvidia through Vanguard S&P 500 ETF (NYSE:VOO) and Invesco QQQ Trust, Series 1 (NASDAQ:QQQ).

Portfolio Pulse from Anusuya Lahiri

June 20, 2024 | 10:10 am

DXCM

DexCom, Inc. (NASDAQ:DXCM) showcased its expanded focus on Type 2 diabetes at the ADA Conference, highlighting the benefits of its CGM systems, including the new Omnipod 5 Automated Insulin Delivery System with Dexcom G7. The company presented data showing significant improvements in A1C and time in range for Type 2 diabetes patients using Dexcom CGM, both on and off insulin. Dexcom also announced the upcoming launch of Stelo, a glucose biosensor for non-insulin users, and emphasized its leadership in CGM connectivity with various insulin pumps.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:08 am

FXI

KWEB

MCHI

TCEHY

JPMorgan analyst Alex Yao has shifted his stance on China's tech sector, predicting a 20-25% increase in stock prices due to improved cost structures and macroeconomic stabilization. ETFs like KWEB, MCHI, and FXI offer exposure to this potential growth.

Portfolio Pulse from Benzinga Neuro

June 20, 2024 | 10:08 am

ABT

DXCM

PODD

Insulet's Omnipod 5, compatible with Dexcom G6 and Abbott Freestyle Libre 2 Plus continuous glucose monitor sensors, is now fully available in the U.K. and Netherlands for individuals aged two years and older with Type 1 diabetes.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:07 am

JOBY

Joby Aviation has received FAA authorization to use its proprietary software suite, ElevateOS, designed for high-tempo, on-demand air taxi operations. The software has been tested over the past two years, leveraging Joby's Part 135 certification.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 10:04 am

TRMB

Trimble has introduced the R980 GNSS system, which aims to enhance work productivity for geospatial professionals.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:55 am